Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

CSE:SONA - Post by User

Sona Nanotech Inc > Abbott beat ya to it

<< Previous

Bullboard Posts

Next >>

Comment by Moemoney42on Oct 07, 2020 2:08pm

132 Views

Post# 31680945

RE:RE:RE:RE:RE:RE:RE:RE:Abbott beat ya to it

whatdoiknow123 wrote:

MOMONEY,

1. In the context of a well-organised massive screening programme it can be done quicker than 5 mins but even if we accept that timescale it is still 3 times more throughput than you claimed. It also means that all those other tests that could do 96 tests could in fact only process 72 per 24 hours. Whichever way you look at it SONA can test many times the number of patients that other tests can. I agree never said they couldn't but when people come on here and state "unlimited" like yourself I have to call you on it..
2. No idea why you talk about blood tests. There are no blood tests and the rest is pure waffle. This was a simple comparison on timelines to do a very simple procedure... obviously it went over you're head
3. They did not have a specific Asymptomatic Test Cohort in the 3 rd party testing. That idea was introduced by the FDA later. The Asymptomatic results of 100%/ 100% in the in-field tests are very promising and they will be working on that as well as saliva for tests 2.0 and 3.0. I and the markets deal with whats on the table today as evidenced by the share price.. the market is what it is..
4. You want to talk about valuation so let´s go although I usually try to avoid doing so.

a. talking about going from 1 cent to $16 is just plain silly. It was at 1 cent for only a few hours because of a specific event. It is not now at $ 16 but $8 and we are interested in what it might do from the position today so don´t confuse with16. Ok I'll be generous with you and use 10 cents as it appears to have traded at for within the same timeline you like to use for you're example.. you're grabbing at straws to make you're point... point is even if a $1 was used the price run to $16 shows SONA moved alot more than your example and we both know you could have bought piles of stock since late 2018 for far less than that
b. as an experienced investor you must know that looking at the share price or the increase in share price is not the most sensible way to value a Company or it´s potential. One looks at the present Market Cap, estimates it´s potential future revenue/profit and works out what it might be worth. As I continue to state... this "potential" could already be priced in... you don't know that it isn't and to say categorically it will rise from here isn't neccessarily true.. although it could have a run I don't deny that.
c. If SONA gets Approval as is pretty certain and achieves decent sales the potential revenue in the near future makes it very clear that this is not yet factored into the current SP. Sales of "only" 20million tests would produce revenues of significantly more that the present Market Cap which would translate into a much higher SP. If successful we expect sales much in excess of 20 million and so potentially a SP in multiples of today, all going well. That is a bold statement with tons of speculation and big "ifs"

Let´s leave the argument at that and not get into a tit for tat endless to and fro. I'm done..